Can Ryzodeg (insulin degludec/insulin aspart) be administered once daily at a total dose of 38 units?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Ryzodeg Be Given Once Daily at 38 Units?

Yes, Ryzodeg (insulin degludec/insulin aspart) can be administered once daily at 38 units, as this falls within the appropriate dosing range for once-daily administration, which is typically initiated at 10 units or 0.1-0.2 units/kg and titrated upward based on glycemic response.

Dosing Framework for Ryzodeg

Once-Daily Dosing is Appropriate

Ryzodeg can be initiated and maintained as once-daily dosing, particularly when given with the main meal containing the largest carbohydrate content 1. The 38-unit dose you're asking about is well within the therapeutic range, as:

  • Starting doses for basal insulin typically begin at 10 units per day or 0.1-0.2 units/kg 2
  • Titration proceeds by increasing 2 units every 3 days to reach fasting plasma glucose goals without hypoglycemia 2
  • A 38-unit dose represents a reasonable titrated dose for many patients

Key Considerations for Once-Daily Dosing

Meal timing is critical: The once-daily injection should be administered with the main meal that has the largest carbohydrate content 1. This maximizes the benefit of the rapid-acting insulin aspart component (30% of the formulation) while the insulin degludec component (70%) provides basal coverage for >24 hours 3.

Pharmacologic properties support once-daily use: The glucose-lowering effect profile shows distinct prandial action from the insulin aspart component followed by flat basal effect lasting beyond 30 hours from the insulin degludec component 3. This ultra-long duration of action exceeding 42 hours allows for flexible once-daily dosing 4.

When to Consider Dose Intensification

Signals That Once-Daily May Be Insufficient

Monitor for these clinical indicators that suggest need for twice-daily dosing:

  • A1C remains above goal despite adequate titration of once-daily dose
  • Elevated postprandial glucose at meals other than the one covered by the injection
  • Bedtime-to-morning glucose differential suggesting inadequate basal coverage
  • High glucose variability throughout the day 2

Transitioning to Twice-Daily

If intensification is needed, split to twice-daily dosing. Important: The split does NOT need to be 50:50 but should match the carbohydrate content of the respective meals 1. For example, if breakfast has more carbohydrates than dinner, allocate more units to the morning dose.

Special Populations Requiring Dose Adjustment

Lower starting doses are recommended for:

  • Patients with cardiac comorbidities
  • Patients with renal impairment 1

In these cases, consider starting at the lower end of the range (10 units or 0.1 units/kg) and titrate more conservatively.

Hypoglycemia Management

If hypoglycemia occurs at the 38-unit dose:

  • Determine the cause (missed meal, increased activity, alcohol intake)
  • If no clear reason identified, reduce dose by 10-20% (approximately 4-8 units) 2
  • Reassess and retitrate cautiously

Clinical Evidence Supporting Once-Daily Dosing

Ryzodeg once-daily provides superior long-term glycemic control compared to insulin glargine with similar fasting plasma glucose, similar insulin doses, and numerically lower rates of overall and nocturnal hypoglycemia 5. The distinct pharmacokinetic profile maintains both prandial and basal effects even with once-daily administration 3, 6.

Common Pitfalls to Avoid

Patient education on the "main meal concept" is essential: Patients may misunderstand and believe they should consume more carbohydrates when taking Ryzodeg. Clarify that the insulin should match their usual carbohydrate intake, not increase it 1.

Don't forget glucagon prescription: Consider prescribing emergency glucagon when initiating or intensifying insulin therapy 2.

Avoid therapeutic inertia: Reassess and modify the regimen every 3-6 months if glycemic goals are not met 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.